ATHEROGENICS INC 4
4 · ATHEROGENICS INC · Filed Jan 5, 2004
Insider Transaction Report
Form 4
ATHEROGENICS INCAGIX
SCOTT ROBERT A
Sr VP Clinical Dev & RA
Transactions
- Award
Incentive Stock Option (Right to Buy)
2003-12-31+66,000→ 66,000 totalExercise: $14.86Exp: 2013-12-31→ Common Stock (66,000 underlying)
Footnotes (1)
- [F1]25% of these options vest on 12/31/2004, the first anniversary of the date of grant. Following that date, the remaining options vest at a rate of 2%-3% per month over the next 36 months.